NuPathe to Present at Upcoming Investor Conferences
February 07 2012 - 4:05PM
Marketwired
NuPathe Inc. (NASDAQ: PATH), an emerging biopharmaceutical company
focused on the development and commercialization of branded
therapeutics for diseases of the central nervous system, today
announced that Jane Hollingsworth, chief executive officer, will
present company overviews at two upcoming investor conferences.
On Tuesday, February 14, 2012, NuPathe will present at the 14th
Annual BIO CEO & Investor Conference at 3:00 p.m. EST. The
conference is being held at The Waldorf Astoria Hotel in New York,
NY.
On Wednesday, February 15, 2012, NuPathe will present at the
Leerink Swann 2012 Global Healthcare Conference at 4:00 p.m. EST.
The conference is also being held at The Waldorf Astoria Hotel in
New York, NY.
Live audio webcasts of the presentations will be available via
the "Investor Relations" page of the NuPathe website,
www.nupathe.com. Please log on through NuPathe's website
approximately 10 minutes prior to the scheduled start time. Replays
of the webcasts will also be archived on NuPathe's website for 90
days following the presentation.
About NuPathe NuPathe Inc.
(www.nupathe.com) is an emerging biopharmaceutical company focused
on innovative neuroscience solutions for diseases of the central
nervous system including neurological and psychiatric disorders.
NuPathe's lead product candidate, NP101, is an active, single-use,
transdermal sumatriptan patch being developed for the treatment of
migraine. In addition to NP101, NuPathe has two additional
proprietary product candidates in preclinical development: NP201
for the continuous symptomatic treatment of Parkinson's disease,
which the company plans to partner, and NP202 for the long-term
treatment of schizophrenia and bipolar disorder.
Contact Information: John Woolford Westwicke Partners,
LLC (443) 213-0506 john.woolford@westwicke.com Keith A. Goldan Vice
President & Chief Financial Officer NuPathe Inc. (484)
567-0130
Nupathe Inc. (MM) (NASDAQ:PATH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nupathe Inc. (MM) (NASDAQ:PATH)
Historical Stock Chart
From Sep 2023 to Sep 2024